Ategrity Specialty Insurance Co Holdings
Filed Mar 24, 2025.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Mar 24, 2025
Contents
Cover page
Show cover page
S-11 tm2428146-4_s1.htm S-1
As filed with the U.S. Securities and Exchange Commission on March 24, 2025.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Ategrity Specialty Holdings LLC*
(Exact name of registrant as specified in its charter)
| | Delaware (State or other jurisdiction of incorporation or organization) | | | 6331 (Primary Standard Industrial Classification Code Number) | | | 82-4925734 (I.R.S. Employer Identification Number) | |
|---|
9 West 57 th Street, 33 rd Floor, New York, NY 10019
Telephone: (212) 509-1600
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Justin Cohen
9 West 57 th Street, 33 rd Floor, New York, NY 10019
Telephone: (212) 509-1600
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
| | Marc D. Jaffe Erika L. Weinberg Gary D. Boss Latham & Watkins LLP 1271 Avenue of the Americas New York, NY 10020 (212) 906-1200 | | | Eric Crespolini Ategrity Specialty Holdings LLC 9 West 57th Street, 33rd Floor, New York, NY 10019 Telephone: (212) 509-1600 | | | Dwight S. Yoo Elena M. Coyle Ryan J. Dzierniejko Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West New York, NY 10001 (212) 735-3000 | |
|---|
Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement is declared effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | Large accelerated filer ☐ | | | Accelerated filer ☐ | |
|---|---|---|---|---|---|
| | Non-accelerated filer ☒ | | | Smaller reporting company ☐ | |
| | | | | Emerging growth company ☒ | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
- Ategrity Specialty Holdings LLC will be converted to a Nevada corporation named Ategrity Specialty Insurance Company Holdings prior to the consummation of this offering.
The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted
Subject to completion, dated , 2025
Preliminary prospectus
shares
This is the initial public offering of shares of common stock of Ategrity Specialty Insurance Company Holdings.
Prior to this offering, there has been no public market for our common stock. The initial public offering price of our common stock is estimated to be between $ and $ per share. We have applied to list our common stock on the New York Stock Exchange (the “NYSE”) under the symbol “ASIC.” The listing will be subject to the approval of our application.
We are an “emerging growth company” as that term is defined in the Jumpstart Our Business Startups Act of 2012, and, as such, have elected to comply with certain reduced public company reporting requirements for this registration statement and may do so in future filings. See “Prospectus summary—Implications of being an emerging growth company.”
Upon completion of this offering, Zimmer Financial Services Group LLC (“ZFSG”) will continue to own more than a majority of the voting power of our shares of common stock eligible to vote in the election of our directors. As a result, we will be a “controlled company” as defined under the corporate governance rules of NYSE and will be exempt from certain corporate governance requirements of such rules. See “Management—Director independence and controlled company exemption.”
Investing in our common stock involves risks. See “Risk factors” beginning on page 16 to read about factors you should consider before purchasing shares of our common stock.
Neither the Securities and Exchange Commission (“SEC”) nor any state securities commission or regulatory authority has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | | | Per share | | | Total | | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | Initial public offering price | | | | $ | | | | | $ | | | ||
| | Underwriting discounts and commissions(1) | | | | $ | | | | | $ | | | ||
| | Proceeds to us, before expenses | | | | $ | | | | | $ | | | | |
(1) See “Underwriting” for a description of compensation to be paid to the underwriters.
At our request, the underwriters have reserved for sale, at the initial public offering price, up to % of the shares offered by this prospectus, excluding the additional shares that the underwriters have an option to purchase, for sale to certain of our employees, certain of our directors and certain other parties. See “Underwriting—Directed Share Program.”
We have granted the underwriters an option for a period of 30 days from the date of this prospectus to purchase up to an additional shares of our common stock from us at the initial public offering price less the underwriting discounts and commissions to cover over-allotments.
The underwriters expect to deliver the shares of common stock through the book-entry facilities of the Depository Trust Company on or about , 2025.
| | J.P. Morgan | | | Barclays | |
|---|
, 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.